Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Clinical Medicine / 臨床醫學研究所
  4. Real-world effectiveness from the asia pacific rim liver consortium for hbv risk score for the prediction of hepatocellular carcinoma in chronic hepatitis b patients treated with oral antiviral therapy
 
  • Details

Real-world effectiveness from the asia pacific rim liver consortium for hbv risk score for the prediction of hepatocellular carcinoma in chronic hepatitis b patients treated with oral antiviral therapy

Journal
Journal of Infectious Diseases
Journal Volume
221
Journal Issue
3
Pages
389-399
Date Issued
2020
Author(s)
Yang H.-I.
Yeh M.-L.
Wong G.L.
Peng C.-Y.
Chen C.-H.
Trinh H.N.
Cheung K.-S.
Xie Q.
TUNG-HUNG SU  
Kozuka R.
Lee D.-H.
Ogawa E.
Zhao C.
Ning H.-B.
Huang R.
Li J.
Zhang J.Q.
Ide T.
Xing H.
Iwane S.
Takahashi H.
Wong C.
Wong C.
Lin C.-H.
Hoang J.
Le A.
Henry L.
Toyoda H.
Ueno Y.
Gane E.J.
Eguchi Y.
Kurosaki M.
Wu C.
Liu C.
Shang J.
Furusyo N.
Enomoto M.
JIA-HORNG KAO  
Yuen M.-F.
Yu M.-L.
Nguyen M.H.
DOI
10.1093/INFDIS/JIZ477
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077946812&doi=10.1093%2fINFDIS%2fJIZ477&partnerID=40&md5=9baefdae23a7d7a31c8ac0e99093cab4
https://scholars.lib.ntu.edu.tw/handle/123456789/581775
Abstract
Background. Patients on oral antiviral (OAV) therapy remain at hepatocellular carcinoma (HCC) risk. Risk prediction tools distinguishing treated patients with residual HCC risk are limited. The aim of this study was to develop an accurate, precise, simple-to-use HCC risk score using routine clinical variables among a treated Asian cohort. Methods. Adult Asian chronic hepatitis B (CHB) patients on OAV were recruited from 25 centers in the United States and the Asia-Pacific region. Excluded persons were coinfected with hepatitis C, D, or human immunodeficiency virus, had HCC before or within 1 year of study entry, or their follow-up was <1 year. Patients were randomized to derivation and validation cohorts on a 2:1 ratio. Statistically significant predictors from multivariate modeling formed the Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV (REAL-B) score. Results. A total of 8048 patients were randomized to the derivation (n = 5365) or validation group (n = 2683). The REAL-B model included 7 variables (male gender, age, alcohol use, diabetes, baseline cirrhosis, platelet count, and alpha fetoprotein), and scores were categorized as follows: 0-3 low risk, 4-7 moderate risk, and 8-13 high risk. Area under receiver operating characteristics were >0.80 for HCC risk at 3, 5, and 10 years, and these were significantly higher than other risk models (p <.001). Conclusions. The REAL-B score provides 3 distinct risk categories for HCC development in Asian CHB patients on OAV guiding HCC surveillance strategy. ? The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. DOI: 10.1093/infdis/jiz477
Subjects
Asian; Liver cancer; Treatment; Viral hepatitis; Viral suppression
SDGs

[SDGs]SDG3

Other Subjects
alpha fetoprotein; antivirus agent; entecavir; lamivudine; peginterferon; telbivudine; tenofovir disoproxil; antivirus agent; virus DNA; adult; age distribution; alcohol consumption; Article; cancer risk; China; chronic hepatitis B; controlled study; diabetes mellitus; disease surveillance; female; follow up; Hepatitis B Virus Risk Score; high risk patient; Hong Kong; human; human cell; intermediate risk patient; Japan; liver cell carcinoma; liver cirrhosis; low risk patient; major clinical study; male; measurement accuracy; measurement precision; New Zealand; platelet count; randomized controlled trial; risk assessment; sex difference; South Korea; Taiwan; United States; validation study; Asia; Asian continental ancestry group; chronic hepatitis B; cohort analysis; ethnology; genetics; Hepatitis B virus; liver cell carcinoma; liver tumor; methodology; middle aged; oral drug administration; proportional hazards model; randomization; receiver operating characteristic; risk assessment; virology; Administration, Oral; Adult; Antiviral Agents; Asia; Asian Continental Ancestry Group; Carcinoma, Hepatocellular; Cohort Studies; Data Accuracy; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Random Allocation; Research Design; Risk Assessment; ROC Curve
Publisher
Oxford University Press
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science